Guardant Health (GH) Price to Earnings (2018 - 2026)

Guardant Health has disclosed Price to Earnings across 9 years of filings, most recently posting 166.85 for Q2 2026.

• In Q2 2026, Price to Earnings fell 157.31% year-over-year to 166.85; the TTM figure through Jun 2026 stood at 44.21 (down 182.42% YoY), while the FY2025 annual figure was 32.05, down 269.25% from the prior year.
• Price to Earnings came in at 166.85 for Q2 2026 at Guardant Health, down from 108.39 in the prior quarter.
• In the past five years, Price to Earnings ranged from a high of 17.59 in Q4 2023 to a low of 166.85 in Q2 2026.
• Average Price to Earnings over 5 years is 53.39, with a median of 37.59 recorded in 2023.
• Year-over-year, Price to Earnings surged 86.06% in 2022 and plunged 222.17% in 2023.
• Over 5 years, Price to Earnings stood at 19.95 in 2022, then grew by 11.82% to 17.59 in 2023, then plunged by 94.0% to 34.12 in 2024, then sank by 204.3% to 103.84 in 2025, then plunged by 60.68% to 166.85 in 2026.
• Per Business Quant data, the three most recent Price to Earnings figures were 166.85 in Q2 2026, 108.39 in Q1 2026, and 103.84 in Q4 2025.